There is a need to improve infectious risk mitigation in adults with diabetes because they are hospitalized for infections between 2.6 and 15.7 times as often as adults without diabetes, depending on the type of infection.
Among individuals with acute myelogenous leukemia (AML), carbapenem-nonsusceptible gram-negative bacteremia (GNB) is associated with worse outcomes than carbapenem-susceptible GNB.
A closed ICU model is associated with a reduction in certain types of hospital-acquired infections.
Infections that require hospitalization and treatment with anti-infective agents in childhood are associated with an increased risk for eating disorders in adolescent girls.
The novel combination antibacterial agent ceftolozane/tazobactam had comparable clinical and microbiologic response rates to meropenem in treating gram-negative nosocomial pneumonia.
A combination dose of ceftolozane/tazobactam is noninferior to meropenem for treating nosocomial pneumonia.
Candida auris can survive on surfaces after routine cleaning and is often drug-resistant
Staphylococcus aureus infections continue to be a cause of significant mortality and morbidity in spite of lower rates of methicillin-resistant S aureus.
Facility-level rates of hospital-onset Clostridioides difficile infection have been found to decrease correspondingly with lower usage of antibiotics.
Researchers conducted a case series to examine the demographics, presentation, management, and outcomes in patients with post-implant calcium pyrophosphate deposition disease.
